Genmab A/S
F:GE91
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genmab A/S
F:GE91
|
DK |
|
Peapack-Gladstone Financial Corp
NASDAQ:PGC
|
US |
|
P
|
Procter & Gamble Co
DUS:PRG
|
US |
|
K
|
Ksign Co Ltd
KOSDAQ:192250
|
KR |
|
M
|
McDonald's Corp
SWB:MDO
|
US |
|
S
|
Sahakol Equipment PCL
SET:SQ
|
TH |
|
K
|
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
|
KR |
|
C
|
Coca-Cola Europacific Partners PLC
MAD:CCEP
|
UK |
|
CIR SpA - Compagnie Industriali Riunite
MIL:CIR
|
IT |
|
E
|
Equita Group SpA
LSE:0DEY
|
IT |
|
T
|
TTW PCL
SET:TTW
|
TH |
|
X
|
Xplus SA
WSE:XPL
|
PL |
|
M
|
Manulife Financial Corp
F:MLU
|
CA |
|
Eurocell PLC
F:6YQ
|
UK |
|
A
|
Asahi Kasei Corp
XMUN:ASAA
|
JP |
|
H
|
Hartford Insurance Group Inc
XMUN:HFF
|
US |
|
W
|
Waters Corp
XMUN:WAZ
|
US |
|
P
|
Pantheon Infrastructure PLC
LSE:PINT
|
UK |
|
Nikon Corp
F:NKN0
|
JP |
|
R
|
Roma Green Finance Ltd
NASDAQ:ROMA
|
HK |
|
D
|
Daimler Truck Holding AG
XMUN:DTG
|
DE |
|
O
|
Occidental Petroleum Corp
F:OPC
|
US |
Bankruptcy Probability
Genmab A/S's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Genmab A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Genmab A/S
CSE:GMAB
|
142.4B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
465.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
229.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
133.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
81.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
87.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Genmab A/S's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Genmab A/S has total debt of 5B USD. This includes both short-term (0 USD) and long-term (5B USD) debt.
You can find a full breakdown on its Balance Sheet.